HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Long-term clinical results of the treatment with bare metal stents of chronic total occlusions].

Abstract
Background. Previous studies have shown that successful recanalization by stent implantation of a chronic total coronary occlusion (CTO) is associated with an improved clinical outcome. However, most of these studies have used first-generation stents and dated regimens of antithrombotic therapy. Methods. We retrospectively investigated the short- and long-term clinical results of current techniques of percutaneous revascularization in 126 consecutive patients with CTO who underwent successful implantation of a new-generation bare metal stent and dual antiplatelet therapy. Results. There were neither in-hospital deaths nor subacute stent thrombosis; periprocedural acute myocardial infarction occurred in 6 (2.3%) patients; 25 (20%) late major events were observed during a mean follow-up of 19 +/- 10 months: one sudden death, two myocardial infarctions, and 22 cases of target vessel revascularization. Length of CTO > 24 mm (odds ratio = 1.06, p < 0.0245) and final minimal lumen diameter < or = 2.5 mm (odds ratio = 0.224, p < 0.01) were identified as independent predictors of late events. Conclusions. The results of current practice of stenting of CTO are encouraging. Only angiographic variables are predictive of long-term clinical outcome.
AuthorsRosario Fiorilli, Francesco De Felice, Antonio Parma, Edoardo Pucci, Maurizio Menichelli, Marco Stefano Nazzaro, Roberto Violini
JournalGiornale italiano di cardiologia (2006) (G Ital Cardiol (Rome)) Vol. 7 Issue 1 Pg. 50-5 (Jan 2006) ISSN: 1827-6806 [Print] Italy
Vernacular TitleRisultati clinici a distanza del trattamento con stent convenzionale delle occlusioni coronariche croniche.
PMID16528962 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Coronary Stenosis (surgery)
  • Equipment Design
  • Female
  • Humans
  • Male
  • Middle Aged
  • Stents
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: